日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti-TIGIT Therapy in Microsatellite-Stable Colorectal Cancer

PRMT5抑制剂与化疗协同作用,诱导类似错配修复缺陷的基因表达,并增强微卫星稳定型结直肠癌中抗TIGIT疗法的疗效

Zhu, Jiang; Fu, Shenao; Zou, Xi; Zeng, Hanjiang; Cui, Guangzu; Peng, Yinghui; Tang, Diya; Zhang, Fan; Shen, Hong; Zeng, Shan; Han, Ying

The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.

从头脂肪生成对预测生存和临床治疗的影响:基于肝细胞癌多基因预后模型的探索

Zhou Xin, Cui Guangzu, Hu Erya, Wang Xinwen, Tang Diya, Zhang Xiangyang, Ma Jiayao, Li Yin, Liu Haicong, Peng Qingping, Han Ying, Chen Yihong, Zeng Shan, Zhang Yan, Shen Hong

The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma.

P53突变相关的DNA损伤和修复的分子特征可用于预测肝细胞癌的复发和免疫治疗反应

Ma Jiayao, Tang Diya, Cui Guangzu, Zhang Xiangyang, Wang Xinwen, Li Yin, Hu Erya, Zhou Xin, Liu Haicong, Peng Qingping, Cai Changjing, Deng Xiangying, Zeng Shan, Chen Yihong, Xiao Zemin

Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells

将“冷”转化为“热”:通过调控肿瘤相关免疫抑制细胞的表观遗传策略提高免疫治疗效果

Tang, Yijia; Cui, Guangzu; Liu, Haicong; Han, Ying; Cai, Changjing; Feng, Ziyang; Shen, Hong; Zeng, Shan